Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07069400 · ClinicalTrials.gov registry record
An International Observational Study of Adults With Acute Infection
A clinical trial of Infectious Disease, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 20
- Study locations
NCT07069400: Recruiting study of Infectious Disease, sponsored by University of Minnesota.
NCT07069400 is a study of Infectious Disease that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 1,500 participants, below the 6,942-participant average among 18 other Infectious Disease trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07069400, a study of Infectious Disease, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.
Primary Outcome
All-cause mortality
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (20)
California
- Stanford University Hospital & Clinics (Site 203-003) - Palo Alto
- UCSF Medical Center (Site 203-001) - San Francisco
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic (Site 054-001) - Rochester
New York
- New York University Langone Health (301-013) - New York
- Mount Sinai Medical Center (Site 301-012) - New York
North Carolina
- Duke University (301-006) - Durham
- Wake Forest Baptist Health (210-001) - Winston-Salem
Arizona
- Banner University Medical Center Tucson - Tucson
Illinois
- University of Illinois at Chicago (Site 008-012) - Chicago
Kansas
- University of Kansas Medical Center (Site 080-044) - Kansas City
Nebraska
- University of Nebraska Medical Center (Site 080-045) - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2027-06-08 |
What NCT07069400 shows while recruiting
NCT07069400 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, below the 6,942-participant average among 18 other Infectious Disease trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT07069400 names 20 study sites across 16 states, led by California, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT07069400 about?
NCT07069400 is a clinical study titled "An International Observational Study of Adults With Acute Infection". Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to ...
What is the current status of trial NCT07069400?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2025-08-25. Estimated completion is 2027-06-08.
What conditions does trial NCT07069400 study?
This clinical trial studies the following conditions: Infectious Disease.
What interventions are being tested in trial NCT07069400?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT07069400?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07069400 being conducted?
This trial has 20 study locations across Arizona, California, Illinois, Kansas, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infectious Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07069400's enrollment target sits among peer trials
1,500 5th of 18 higher than 14 of 18 other Infectious Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infectious Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Compliant Analysis of Patient Samples and Data
RECRUITING
-
Collection and Distribution of Biospecimens for Novel Research Uses
RECRUITING
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
Triage Survey for Infectious Disease Eligibility
RECRUITING
-
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
RECRUITING · NA
-
Pharmacogenomics for Better Treatment of Fungal Infections in Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI